Rohini K. Hernandez, PhD MPH (she/her/hers)

Director of Observational Research
Amgen, Inc.
Thousand Oaks, CA, United States

Rohini Hernandez, PhD, MPH, is a Director of Observational Research in the Center for Observational Research at Amgen, Inc. Rohini leads a Pharmacovigilance Epidemiology team focused on leveraging real-world data to evaluate the safety of medications across therapeutic areas, including post-approval safety studies and post-marketing requirements to support benefit/risk assessments globally. Rohini’s experience includes descriptive and comparative effectiveness studies to support new indications, label expansion applications, and post-marketing drug utilization and comparative safety studies. Her research interests include exploring methods for controlling biases in pharmacoepidemiology studies and identifying opportunities for improved assessment of product safety during pregnancy. She received her PhD in Epidemiology from Boston University School of Public Health and her MPH in Epidemiology from The George Washington University.

Disclosure information not submitted.

Presentation(s):

• OP1-2 - Characterizing Fit-for-Purpose Real-World Data: An Assessment of a Mother–Infant Linkage in the Japan Medical Data Center Claims Database

  Monday, April 24, 2023
  2:15 PM – 3:45 PM GMT